Focused Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Focused Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5	Closed	-$2.77K	–	542
2023 Q4	$2.77K	Hold	5	–	–	﹤0.01%	736
2023 Q3	$2.19K	Hold	5	–	–	﹤0.01%	755
2023 Q2	$2.51K	Hold	5	–	–	﹤0.01%	778
2023 Q1	$2.5K	Hold	5	–	–	﹤0.01%	769
2022 Q4	$2.04K	Hold	5	–	–	﹤0.01%	774
2022 Q3	$2K	Hold	5	–	–	﹤0.01%	757
2022 Q2	$2K	Hold	5	–	–	﹤0.01%	734
2022 Q1	$3K	Hold	5	–	–	﹤0.01%	745
2021 Q4	$3K	Hold	5	–	–	﹤0.01%	754
2021 Q3	$3K	Hold	5	–	–	﹤0.01%	773
2021 Q2	$3K	Hold	5	–	–	﹤0.01%	784
2021 Q1	$2K	Hold	5	–	–	﹤0.01%	804
2020 Q4	$2K	Hold	5	–	–	﹤0.01%	735
2020 Q3	$2K	Hold	5	–	–	﹤0.01%	694
2020 Q2	$2K	Hold	5	–	–	﹤0.01%	674
2020 Q1	$1K	Hold	5	–	–	﹤0.01%	654
2019 Q4	$1K	Hold	5	–	–	﹤0.01%	674
2019 Q3	$1K	Hold	5	–	–	﹤0.01%	665
2019 Q2	$1K	Hold	5	–	–	﹤0.01%	696
2019 Q1	$1K	Buy	+5	New	+$1.03K	﹤0.01%	651

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focused Wealth Management's IDXX Position: Q1 2024 in Review

Focused Wealth Management sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 5 shares — an estimated $2.77K sold.

Focused Wealth Management first reported a position in IDXX in Q1 2019 and held it in 20 quarters. The position peaked at $3K in Q1 2022. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Focused Wealth Management reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Focused Wealth Management sold 5 Idexx Laboratories shares in Q1 2024, an estimated $2.77K.
Focused Wealth Management first reported a position in Idexx Laboratories in Q1 2019 and held it in 20 quarters.
Focused Wealth Management's Idexx Laboratories position peaked at $3K in Q1 2022.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.